SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

CNS Pharmacology

» Start this Course
(Practice similar questions for free)
Question:

Natalizumab

Author: Suzuki



Answer:

A monoclonal antibody, natalizumab, is also indicated for MS in patients who have failed first-line therapies.


0 / 5  (0 ratings)

1 answer(s) in total

Author

Suzuki
Suzuki